Company Profile
NeuroOne Medical Technologies Stock Price, News & Catalysts
- Ticker:
- NMTC
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
2.15 USD (-1.38%)
Close
Last updated: August 20, 2026
30.7M USD
Market cap
Why the stock is moving
As of Aug 20, 2026, NMTC closed down 1.38% at $2.15. No new same-company headline was identified in the current news window.
Company overview
Business overview
NeuroOne Medical Technologies is a medical technology company focused on neurodiagnostic and neurosurgical tools. Its products are aimed at improving procedures and monitoring in the neurology and epilepsy workflow.
Geographic Base and Sector Classification
NeuroOne is headquartered in the United States and listed on NASDAQ. It sits in medical devices rather than biotechnology.
Business Model Characteristics
The business depends on device adoption, hospital and physician workflow integration, and the ability to expand product utilization across neurological procedures. Investors watch capital sales, product clearances, and commercial execution.
Position Within the Biotechnology Landscape
NeuroOne is part of the neurology-device layer of healthcare, not biotech. Its stock is driven by procedural adoption and product rollout rather than drug catalysts.
Future catalysts
- NeuroOne’s catalysts are minimally invasive neurology devices and adoption in epilepsy / neurosurgery workflows. The stock will respond to whether the installed base keeps expanding.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of NeuroOne Medical Technologies (NMTC)?
NeuroOne Medical Technologies (NMTC) most recently closed at 2.15 USD, a -1.38% move versus the previous session.
What is the market cap of NeuroOne Medical Technologies (NMTC)?
NeuroOne Medical Technologies currently has a market capitalization of 30.7M USD on BioPharmSignal.
What does NeuroOne Medical Technologies do?
NeuroOne Medical Technologies is a medical technology company focused on neurodiagnostic and neurosurgical tools. Its products are aimed at improving procedures and monitoring in the neurology and epilepsy workflow.
On which exchange is NMTC stock listed?
NeuroOne Medical Technologies (NMTC) is associated with NASDAQ, United States, Biopharma.
What is NeuroOne?
NeuroOne’s catalysts are minimally invasive neurology devices and adoption in epilepsy / neurosurgery workflows.
Which conditions is NeuroOne Medical Technologies targeting with NeuroOne?
NeuroOne Medical Technologies is associated with neurology based on its company overview and current catalyst commentary.
How does NeuroOne Medical Technologies describe recent progress with NeuroOne?
NeuroOne’s catalysts are minimally invasive neurology devices and adoption in epilepsy / neurosurgery workflows.
What is Medical?
NeuroOne Medical Technologies is a medical technology company focused on neurodiagnostic and neurosurgical tools.